Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
2/7/2026
China Moves to Accelerate New Healthcare Insurance Models and Large‑S...
2/6/2026
Kelun-Biotech Expands Breast Cancer Indications of sac-TMT in China
2/6/2026
Genturn Life Raises CNY Tens of Millions in Angel Round to Advance Re...
2/6/2026
Merck's Keytruda Wins New China Approval for Frontline Endometrial Can...
2/6/2026
DCH Auriga Teams Up with Hengrui to Expand Innovative Medicines in HK ...
2/6/2026
Everest Medicines Gains Chinese Approval for VELSIPITY® in UC
2/6/2026
China Launches Nationwide Crackdown on BMI Fraud in Mental Health Sect...
2/5/2026
Novo Nordisk Reports First Decline in Ozempic Sales in Greater China
2/5/2026
Fosun Secures Priority Review in China for Luvometinib's New Indicatio...
2/5/2026
AmCham China Hosts US FDA Delegation to Strengthen Regulatory Dialogue
2/5/2026
Ascentage Secures China IND Clearance for Next-Gen BTK Degrader APG-32...
2/5/2026
Evogene and Lishan Biopharma Partner to Develop Microbiome Therapy for...
2/5/2026
Everest Medicines Licenses Micot's MT1013 for SHPT in China and Asia-P...
2/5/2026
Angitia Biopharma Raises $130M in Series D Financing to Advance Pipeli...
2/5/2026
Eisai Secures Exclusive Rights to Henlius' Anti-PD-1 Antibody Serpluli...
2/5/2026
iMBioRay Raises Nearly CNY 200M Series B to Advance NK Cell Therapy P...
2/5/2026
Shanghai Pharma Exits BMS China, Closing a Chapter for JV Pharma in Ch...
2/5/2026
2026 National Conference on Drug Registration and Post-Market Regulati...
2/5/2026
CDE Issues Trial Guideline for Neuropathic Pain Drug Development
2/5/2026
CDE Issues Technical Guideline for Clinical Trials of Chronic Insomnia...
2/4/2026
Innovent Advances IL-15 Antibody IBI3013 Into Clinical Trials for Viti...
2/4/2026
China Clears BeBetter Med Dual-Target siRNA Therapy for Combined Hyper...
2/4/2026
Vertex Takes Global Control of WuXi Biologics Trispecific T-Cell Engag...
2/4/2026
Novartis Secures Global Rights to SciNeuro’s Next-Gen Alzheimer’s An...
2/4/2026
Chia Tai Tianqing's Anlotinib New Indication Application Rejected
2/4/2026
China Gene‑Editing Startup AccurEdit Raises $75M to Advance Promising...
2/4/2026
WuXi Biologics and Sinorda Join Forces to Develop Bispecific Antibody ...
2/4/2026
Almirall's Seysara Approved in China for Moderate-to-Severe Acne
2/4/2026
Ant Group's AI Health Chatbot Surges in Popularity Amid China's Overbu...
2/4/2026
China's Health Insurance Market Poised for $596B Surge by 2033
Page:
1
/
61
Total number of articles:
1804
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit